{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:02:41Z","timestamp":1793275361585,"version":"4.5.0"},"reference-count":142,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.lfs.2023.121532","type":"journal-article","created":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T20:49:23Z","timestamp":1677530963000},"page":"121532","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["Insights on benzodiazepines' potential in Alzheimer's disease"],"prefix":"10.1016","volume":"320","author":[{"given":"Hayder M.","family":"Al-Kuraishy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali I.","family":"Al-Gareeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulrahman A.","family":"Alsayegh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wafaa Fouzi","family":"Abusudah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najlaa Hamed","family":"Almohmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omayma A.","family":"Eldahshan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman A.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaber El-Saber","family":"Batiha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.lfs.2023.121532_bb0005","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.3390\/brainsci12101290","article-title":"Statins use in Alzheimer's disease: bane or boon from frantic search and narrative review","volume":"12","author":"Alsubaie","year":"2022","journal-title":"Brain Sci."},{"issue":"1","key":"10.1016\/j.lfs.2023.121532_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41572-020-00234-1","volume":"7","year":"2021","journal-title":"Nat. Rev. Dis. Primers."},{"key":"10.1016\/j.lfs.2023.121532_bb0015","first-page":"1","article-title":"A potential link between visceral obesity and risk of Alzheimer's disease","volume":"21","author":"Al-Kuraishy","year":"2022","journal-title":"Neurochem. Res."},{"issue":"2","key":"10.1016\/j.lfs.2023.121532_bb0020","doi-asserted-by":"crossref","first-page":"70","DOI":"10.4103\/bc.bc_42_19","article-title":"Involvement of orexinergic system in psychiatric and neurodegenerative disorders: a scoping review","volume":"6","author":"Al-Kuraishy","year":"2020","journal-title":"Brain Circ."},{"issue":"132","key":"10.1016\/j.lfs.2023.121532_bb0025","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.phrs.2018.04.017","article-title":"Stress as risk factor for Alzheimer's disease","volume":"1","author":"Caruso","year":"2018","journal-title":"Pharmacol. Res."},{"issue":"3","key":"10.1016\/j.lfs.2023.121532_bb0030","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s12640-019-00105-y","article-title":"Common variant in TREM1 influencing brain amyloid deposition in mild cognitive impairment and Alzheimer's disease","volume":"37","author":"Liu","year":"2020","journal-title":"Neurotox. Res."},{"issue":"1","key":"10.1016\/j.lfs.2023.121532_bb0035","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00401-020-02234-7","article-title":"Accumulation of amyloid precursor protein C-terminal fragments triggers mitochondrial structure, function, and mitophagy defects in Alzheimer's disease models and human brains","volume":"141","author":"Vaillant-Beuchot","year":"2021","journal-title":"Acta Neuropathol."},{"issue":"1","key":"10.1016\/j.lfs.2023.121532_bb0040","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4103\/1673-5374.313016","article-title":"Presenilin mutations and their impact on neuronal differentiation in Alzheimer's disease","volume":"17","author":"Hern\u00e1ndez-Sapi\u00e9ns","year":"2022","journal-title":"Neural Regen. Res."},{"issue":"9","key":"10.1016\/j.lfs.2023.121532_bb0045","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41582-019-0228-7","article-title":"Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies","volume":"15","author":"Yamazaki","year":"2019","journal-title":"Nat. Rev. Neurol."},{"issue":"5","key":"10.1016\/j.lfs.2023.121532_bb0050","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.3390\/ijms20051177","article-title":"The contribution of genetic factors to cognitive impairment and dementia: apolipoprotein E gene, gene interactions, and polygenic risk","volume":"20","author":"Fan","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"132","key":"10.1016\/j.lfs.2023.121532_bb0055","article-title":"Melatonin regulates A\u03b2 production\/clearance balance and A\u03b2 neurotoxicity: a potential therapeutic molecule for Alzheimer's disease","volume":"1","author":"Li","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"28","key":"10.1016\/j.lfs.2023.121532_bb0060","doi-asserted-by":"crossref","first-page":"5347","DOI":"10.1523\/JNEUROSCI.0250-20.2020","article-title":"A role of low-density lipoprotein receptor-related protein 4 (LRP4) in astrocytic A\u03b2 clearance","volume":"40","author":"Zhang","year":"2020","journal-title":"J. Neurosci."},{"key":"10.1016\/j.lfs.2023.121532_bb0065","doi-asserted-by":"crossref","first-page":"5541","DOI":"10.2147\/IJN.S200490","article-title":"Alzheimer's disease: pathogenesis, diagnostics, and therapeutics","volume":"14","author":"Tiwari","year":"2019","journal-title":"Int. J. Nanomedicine"},{"issue":"16","key":"10.1016\/j.lfs.2023.121532_bb0070","doi-asserted-by":"crossref","first-page":"6253","DOI":"10.1074\/jbc.RA118.006230","article-title":"In vivo localization of human acetylcholinesterase-derived species in a \u03b2-sheet conformation at the core of senile plaques in Alzheimer's disease","volume":"294","author":"Jean","year":"2019","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.lfs.2023.121532_bb0075","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41583-018-0113-1","article-title":"Beyond the neuron\u2013cellular interactions early in Alzheimer disease pathogenesis","volume":"20","author":"Henstridge","year":"2019","journal-title":"Nat. Rev. Neurosci."},{"issue":"2","key":"10.1016\/j.lfs.2023.121532_bb0080","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41588-020-00773-z","article-title":"Integrating human brain proteomes with genome-wide association data implicates new proteins in Alzheimer's disease pathogenesis","volume":"53","author":"Wingo","year":"2021","journal-title":"Nat. Genet."},{"issue":"24","key":"10.1016\/j.lfs.2023.121532_bb0085","doi-asserted-by":"crossref","first-page":"5848","DOI":"10.1080\/14786419.2020.1795853","article-title":"Neuroprotective effects of Sophora secundiflora, Sophora tomentosa leaves and formononetin on scopolamine-induced dementia","volume":"35","author":"Aly","year":"2021","journal-title":"Nat. Prod. Res."},{"issue":"8","key":"10.1016\/j.lfs.2023.121532_bb0090","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.4103\/1673-5374.235240","article-title":"Gamma-aminobutyric acid a receptors in Alzheimer's disease: highly localized remodeling of a complex and diverse signaling pathway","volume":"13","author":"Kwakowsky","year":"2018","journal-title":"Neural Regen. Res."},{"issue":"11","key":"10.1016\/j.lfs.2023.121532_bb0095","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3389\/fnagi.2019.00344","article-title":"Benzodiazepines and related drugs as a risk factor in Alzheimer's disease dementia","volume":"8","author":"Ettcheto","year":"2020","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.lfs.2023.121532_bb0100","first-page":"12","article-title":"The potential role of pancreatic \u03b3-aminobutyric acid (GABA) in diabetes mellitus: a critical reappraisal","author":"Al-Kuraishy","year":"2021","journal-title":"Int. J. Prev. Med."},{"issue":"2","key":"10.1016\/j.lfs.2023.121532_bb0105","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.neuron.2008.07.002","article-title":"Neuropeptide S-mediated control of fear expression and extinction: role of intercalated GABAergic neurons in the amygdala","volume":"59","author":"J\u00fcngling","year":"2008","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.lfs.2023.121532_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1326-9-48","article-title":"Oligomeric A\u03b2-induced synaptic dysfunction in Alzheimer's disease","volume":"9","author":"Tu","year":"2014","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.lfs.2023.121532_bb0115","first-page":"1","article-title":"SIRT1 pathway in Parkinson's disease: a faraway snapshot but so close","volume":"29","author":"Batiha","year":"2022","journal-title":"Inflammopharmacology"},{"issue":"470","key":"10.1016\/j.lfs.2023.121532_bb0120","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.neuroscience.2021.06.037","article-title":"The role of the GABAergic system in diseases of the central nervous system","volume":"21","author":"Zhang","year":"2021","journal-title":"Neuroscience"},{"issue":"19","key":"10.1016\/j.lfs.2023.121532_bb0125","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1002\/elps.201100139","article-title":"Analysis of chiral amino acids in cerebrospinal fluid samples linked to different stages of Alzheimer disease","volume":"32","author":"Samakashvili","year":"2011","journal-title":"Electrophoresis"},{"key":"10.1016\/j.lfs.2023.121532_bb0130","first-page":"28","article-title":"Diminished perisomatic GABAergic terminals on cortical neurons adjacent to amyloid plaques","author":"Garcia-Marin","year":"2009","journal-title":"Front. Neuroanat."},{"issue":"2","key":"10.1016\/j.lfs.2023.121532_bb0135","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3233\/JAD-2011-110830","article-title":"Hippocampal GABAergic neurons are susceptible to amyloid-\u03b2 toxicity in vitro and are decreased in number in the Alzheimer's disease TgCRND8 mouse model","volume":"29","author":"Krantic","year":"2012","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.lfs.2023.121532_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-015-0061-4","article-title":"Loss of Munc18-1 long splice variant in GABAergic terminals is associated with cognitive decline and increased risk of dementia in a community sample","volume":"10","author":"Ramos-Miguel","year":"2015","journal-title":"Mol. Neurodegener."},{"issue":"1","key":"10.1016\/j.lfs.2023.121532_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-015-0013-z","article-title":"Synaptic dysfunction and septin protein family members in neurodegenerative diseases","volume":"10","author":"Marttinen","year":"2015","journal-title":"Mol. Neurodegener."},{"issue":"6","key":"10.1016\/j.lfs.2023.121532_bb0150","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.18632\/aging.101870","article-title":"GABAergic astrocytes in Alzheimer's disease","volume":"11","author":"Garaschuk","year":"2019","journal-title":"Aging"},{"issue":"2","key":"10.1016\/j.lfs.2023.121532_bb0155","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3233\/JAD-2011-110830","article-title":"Hippocampal GABAergic neurons are susceptible to amyloid-\u03b2 toxicity in vitro and are decreased in number in the Alzheimer's disease TgCRND8 mouse model","volume":"29","author":"Krantic","year":"2012","journal-title":"J. Alzheimers Dis."},{"issue":"13","key":"10.1016\/j.lfs.2023.121532_bb0160","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.2174\/1389450123666220810102406","article-title":"Central effects of ivermectin in alleviation of Covid-19-induced dysautonomia","volume":"23","author":"Al-Kuraishy","year":"2022","journal-title":"Curr. Drug Targets"},{"issue":"8","key":"10.1016\/j.lfs.2023.121532_bb0165","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/nm.3639","article-title":"GABA from reactive astrocytes impairs memory in mouse models of Alzheimer's disease","volume":"20","author":"Jo","year":"2014","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.lfs.2023.121532_bb0170","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1523\/JNEUROSCI.1446-19.2019","article-title":"SIRT3 haploinsufficiency aggravates loss of GABAergic interneurons and neuronal network hyperexcitability in an Alzheimer's disease model","volume":"40","author":"Cheng","year":"2020","journal-title":"J. Neurosci."},{"issue":"11","key":"10.1016\/j.lfs.2023.121532_bb0175","doi-asserted-by":"crossref","first-page":"8592","DOI":"10.1007\/s12035-018-0977-0","article-title":"Amyloid-\u03b2 increases tau by mediating sirtuin 3 in Alzheimer's disease","volume":"55","author":"Yin","year":"2018","journal-title":"Mol. Neurobiol."},{"issue":"3","key":"10.1016\/j.lfs.2023.121532_bb0180","doi-asserted-by":"crossref","first-page":"969","DOI":"10.3233\/JAD-180995","article-title":"Preliminary report on the feasibility and efficacy of the modified Atkins diet for treatment of mild cognitive impairment and early Alzheimer's disease","volume":"68","author":"Brandt","year":"2019","journal-title":"J. Alzheimers Dis."},{"issue":"4","key":"10.1016\/j.lfs.2023.121532_bb0185","doi-asserted-by":"crossref","DOI":"10.1111\/jsr.13229","article-title":"Pharmacological and non-pharmacological interventions to enhance sleep in mild cognitive impairment and mild Alzheimer's disease: a systematic review","volume":"30","author":"Blackman","year":"2021","journal-title":"J. Sleep Res."},{"issue":"2","key":"10.1016\/j.lfs.2023.121532_bb0190","first-page":"144","article-title":"The use of benzodiazepines in the aged patient: clinical and pharmacological considerations","volume":"21","author":"Dailly","year":"2008","journal-title":"Pak. J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.lfs.2023.121532_bb0195","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s40268-019-00282-3","article-title":"Prediction of drug\u2013drug interactions between opioids and overdosed benzodiazepines using physiologically based pharmacokinetic (PBPK) modeling and simulation","volume":"19","author":"Ji","year":"2019","journal-title":"Drugs R&D"},{"issue":"2","key":"10.1016\/j.lfs.2023.121532_bb0200","first-page":"32","article-title":"Clinical significant effect of chloral hydrate: diazepam combination in the induction of sedation during auditory brainstem response in children with hearing loss","volume":"1","author":"Al-Kuraishy","year":"2016","journal-title":"Int. J. Psychol. Brain Sci."},{"issue":"1","key":"10.1016\/j.lfs.2023.121532_bb0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12917-021-02805-0","article-title":"First-line management of canine status epilepticus at home and in hospital-opportunities and limitations of the various administration routes of benzodiazepines","volume":"17","author":"Charalambous","year":"2021","journal-title":"BMC Vet. Res."},{"issue":"8","key":"10.1016\/j.lfs.2023.121532_bb0210","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.3390\/jcm10081754","article-title":"Time is brain: acute control of repetitive seizures and status epilepticus using alternative routes of administration of benzodiazepines","volume":"10","author":"Almohaish","year":"2021","journal-title":"J. Clin. Med."},{"issue":"3","key":"10.1016\/j.lfs.2023.121532_bb0215","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/10408444.2021.1907303","article-title":"Designer benzodiazepines versus prescription benzodiazepines: can structural relation predict the next step?","volume":"51","author":"Moustafa","year":"2021","journal-title":"Crit. Rev. Toxicol."},{"issue":"5","key":"10.1016\/j.lfs.2023.121532_bb0220","doi-asserted-by":"crossref","first-page":"208","DOI":"10.9740\/mhc.2018.09.208","article-title":"Coadministration of intramuscular olanzapine and benzodiazepines in agitated patients with mental illness","volume":"8","author":"Williams","year":"2018","journal-title":"Ment. Health Clin."},{"key":"10.1016\/j.lfs.2023.121532_bb0225","first-page":"1","article-title":"Anticonvulsant agents: benzodiazepines (clobazam, clonazepam, diazepam, lorazepam, midazolam)","author":"Brigo","year":"2020","journal-title":"NeuroPsychopharmacotherapy"},{"issue":"8","key":"10.1016\/j.lfs.2023.121532_bb0230","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1002\/dta.2387","article-title":"Experimental versus theoretical log D7. 4, pKa and plasma protein binding values for benzodiazepines appearing as new psychoactive substances","volume":"10","author":"Manchester","year":"2018","journal-title":"Drug Test. Anal."},{"issue":"11","key":"10.1016\/j.lfs.2023.121532_bb0235","doi-asserted-by":"crossref","first-page":"566","DOI":"10.3390\/md18110566","article-title":"Interaction of Thalassia testudinum metabolites with cytochrome P450 enzymes and its effects on benzo (a) pyrene-induced mutagenicity","volume":"18","author":"Delgado-Roche","year":"2020","journal-title":"Mar. Drugs"},{"issue":"2","key":"10.1016\/j.lfs.2023.121532_bb0240","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.bpa.2018.06.007","article-title":"New benzodiazepines for sedation","volume":"32","author":"Cornett","year":"2018","journal-title":"Best Pract. Res. Clin. Anaesthesiol."},{"key":"10.1016\/j.lfs.2023.121532_bb0245","doi-asserted-by":"crossref","first-page":"530","DOI":"10.37358\/RC.17.3.5495","article-title":"Fast and simple method for simultaneous detection and quantification of diazepam and desmethyldiazepam in plasma samples in psychiatric patients by GC-MS-FID","volume":"68","author":"Vlad","year":"2017","journal-title":"Rev. Chim."},{"key":"10.1016\/j.lfs.2023.121532_bb0250","series-title":"StatPearls [Internet]","article-title":"Benzodiazepines","author":"Bounds","year":"2021"},{"issue":"241","key":"10.1016\/j.lfs.2023.121532_bb0255","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.envpol.2018.06.042","article-title":"The interactions of fullerene C60 and benzo (\u03b1) pyrene influence their bioavailability and toxicity to zebrafish embryos","volume":"1","author":"Della Torre","year":"2018","journal-title":"Environ. Pollut."},{"issue":"11","key":"10.1016\/j.lfs.2023.121532_bb0260","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3389\/fnagi.2019.00344","article-title":"Benzodiazepines and related drugs as a risk factor in Alzheimer's disease dementia","volume":"8","author":"Ettcheto","year":"2020","journal-title":"Front. Aging Neurosci."},{"issue":"1","key":"10.1016\/j.lfs.2023.121532_bb0265","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/00002093-199803000-00002","article-title":"Benzodiazepines may have protective effects against Alzheimer disease","volume":"12","author":"Fastbom","year":"1998","journal-title":"Alzheimer Dis. Assoc. Disord."},{"issue":"6","key":"10.1016\/j.lfs.2023.121532_bb0270","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1176\/appi.ajp.2020.20040375","article-title":"Do benzodiazepines cause Alzheimer's disease?","volume":"177","author":"Salzman","year":"2020","journal-title":"Am. J. Psychiatr."},{"issue":"10","key":"10.1016\/j.lfs.2023.121532_bb0275","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyv055","article-title":"Use of benzodiazepines in Alzheimer's disease: a systematic review of literature","volume":"1;18","author":"Defrancesco","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"3\u20134","key":"10.1016\/j.lfs.2023.121532_bb0280","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000454881","article-title":"Benzodiazepine use and risk of dementia in the elderly population: a systematic review and meta-analysis","volume":"47","author":"Islam","year":"2016","journal-title":"Neuroepidemiology"},{"issue":"2","key":"10.1016\/j.lfs.2023.121532_bb0285","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.pnpbp.2010.01.004","article-title":"Novel positive allosteric modulators of GABAA receptors: do subtle differences in activity at \u03b11 plus \u03b15 versus \u03b12 plus \u03b13 subunits account for dissimilarities in behavioral effects in rats?","volume":"34","author":"Savi\u0107","year":"2010","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.lfs.2023.121532_bb0290","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1111\/j.1471-4159.2007.04832.x","article-title":"GABAA receptors in aging and Alzheimer's disease","volume":"103","author":"Rissman","year":"2007","journal-title":"J. Neurochem."},{"issue":"9","key":"10.1016\/j.lfs.2023.121532_bb0295","doi-asserted-by":"crossref","first-page":"538","DOI":"10.4140\/TCP.n.2013.538","article-title":"The history of benzodiazepines","volume":"28","author":"Wick","year":"2013","journal-title":"Consult. Pharm."},{"issue":"6","key":"10.1016\/j.lfs.2023.121532_bb0300","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1097\/AOG.0000000000003267","article-title":"Patterns of prescription opioid use in women with endometriosis: evaluating prolonged use, daily dose, and concomitant use with benzodiazepines","volume":"133","author":"Lamvu","year":"2019","journal-title":"Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.lfs.2023.121532_bb0305","first-page":"67","article-title":"The role of GABA neurotransmitter in the human central nervous system, physiology, and pathophysiology","volume":"22","author":"Ochoa-de la Paz","year":"2021","journal-title":"Rev. Mex. Neurocienc."},{"issue":"9","key":"10.1016\/j.lfs.2023.121532_bb0310","article-title":"Axonal mechanisms mediating \u03b3-aminobutyric acid receptor type A (GABA-A) inhibition of striatal dopamine release","volume":"1","author":"Kramer","year":"2020","journal-title":"eLife"},{"issue":"4","key":"10.1016\/j.lfs.2023.121532_bb0315","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1124\/pr.117.014449","article-title":"International Union of Basic and Clinical Pharmacology. CVI: GABAA receptor subtype-and function-selective ligands: key issues in translation to humans","volume":"70","author":"Sieghart","year":"2018","journal-title":"Pharmacol. Rev."},{"issue":"12","key":"10.1016\/j.lfs.2023.121532_bb0320","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1080\/01616412.2021.1949689","article-title":"The preventative effect of of Ro5-4864 (peripheral benzodiazepine receptor agonist) on spinal epidural fibrosis after laminectomy in a rat model","volume":"43","author":"Keskin","year":"2021","journal-title":"Neurol. Res."},{"key":"10.1016\/j.lfs.2023.121532_bb0325","article-title":"Benzodiazepines for treatment of patients with delirium excluding those who are cared for in an intensive care unit","volume":"2","author":"Li","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.lfs.2023.121532_bb0330","article-title":"Benzodiazepines for treatment of patients with delirium excluding those who are cared for in an intensive care unit","volume":"2","author":"Li","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1","key":"10.1016\/j.lfs.2023.121532_bb0335","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40780-018-0106-2","article-title":"Analyses of non-benzodiazepine-induced adverse events and prognosis in elderly patients based on the Japanese adverse drug event report database","volume":"4","author":"Noguchi","year":"2018","journal-title":"J. Pharm. Health Care Sci."},{"key":"10.1016\/j.lfs.2023.121532_bb0340","first-page":"1","article-title":"Abuses and misuses of benzodiazepines and antidepressents; a review","volume":"1","author":"Arshad","year":"2018","journal-title":"Mod. Appl. Pharm. Pharmacol."},{"issue":"9","key":"10.1016\/j.lfs.2023.121532_bb0345","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1097\/CCM.0000000000003231","article-title":"On benzodiazepines, paradoxical agitation, hyperactive delirium, and chloride homeostasis","volume":"46","author":"Schieveld","year":"2018","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.lfs.2023.121532_bb0350","article-title":"Paradoxical excitation following intravenous lorazepam administration for alcohol withdrawal\u2013a case presentation and literature review","volume":"24","author":"Gonzalez","year":"2022","journal-title":"J. Pharm. Pract."},{"issue":"2","key":"10.1016\/j.lfs.2023.121532_bb0355","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2165\/0002512-200926020-00003","article-title":"How do different age groups use benzodiazepines and antidepressants","volume":"26","author":"Smith","year":"2009","journal-title":"Drugs Aging"},{"issue":"3","key":"10.1016\/j.lfs.2023.121532_bb0360","doi-asserted-by":"crossref","first-page":"648","DOI":"10.3390\/neurolint14030053","article-title":"Novel designer benzodiazepines: comprehensive review of evolving clinical and adverse effects","volume":"14","author":"Edinoff","year":"2022","journal-title":"Neurol. Int."},{"issue":"6","key":"10.1016\/j.lfs.2023.121532_bb0365","doi-asserted-by":"crossref","DOI":"10.1111\/jsr.13678","article-title":"Prevalence of exposure to benzodiazepines among pregnant women in Taiwan: a nationwide longitudinal study","volume":"31","author":"Lin","year":"2022","journal-title":"J. Sleep Res."},{"key":"10.1016\/j.lfs.2023.121532_bb0370","series-title":"Perinatal Psychopharmacology","first-page":"203","article-title":"Benzodiazepines and Z-drugs in pregnancy","author":"Bellantuono","year":"2019"},{"issue":"6","key":"10.1016\/j.lfs.2023.121532_bb0375","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1007\/s41999-020-00376-1","article-title":"Polypharmacy, benzodiazepines, and antidepressants, but not antipsychotics, are associated with increased falls risk in UK care home residents: a prospective multi-centre study","volume":"11","author":"Izza","year":"2020","journal-title":"Eur. Geriatr. Med."},{"issue":"4","key":"10.1016\/j.lfs.2023.121532_bb0380","doi-asserted-by":"crossref","first-page":"594","DOI":"10.3390\/neurolint13040059","article-title":"Benzodiazepines: uses, dangers, and clinical considerations","volume":"13","author":"Edinoff","year":"2021","journal-title":"Neurol. Int."},{"issue":"7","key":"10.1016\/j.lfs.2023.121532_bb0385","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1007\/s11739-020-02339-7","article-title":"Risk of hospitalisation associated with benzodiazepines and z-drugs in Italy: a nationwide multicentre study in emergency departments","volume":"15","author":"Lombardi","year":"2020","journal-title":"Intern. Emerg. Med."},{"issue":"8","key":"10.1016\/j.lfs.2023.121532_bb0390","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003029","article-title":"GABAA receptor-mediated acceleration of aging-associated memory decline in APP\/PS1 mice and its pharmacological treatment by picrotoxin","volume":"3","author":"Yoshiike","year":"2008","journal-title":"PloS one"},{"key":"10.1016\/j.lfs.2023.121532_bb0395","series-title":"Anxiety in the Elderly: Treatment and Research","author":"Salzman","year":"1991"},{"issue":"3","key":"10.1016\/j.lfs.2023.121532_bb0400","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0887-6177(03)00096-9","article-title":"Persistence of cognitive effects after withdrawal from long-term benzodiazepine use: a meta-analysis","volume":"19","author":"Barker","year":"2004","journal-title":"Arch. Clin. Neuropsychol."},{"issue":"10","key":"10.1016\/j.lfs.2023.121532_bb0405","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1136\/jech-2011-200314","article-title":"Benzodiazepine use and risk of dementia: evidence from the Caerphilly prospective study (CaPS)","volume":"66","author":"Gallacher","year":"2012","journal-title":"J. Epidemiol. Community Health"},{"issue":"349","key":"10.1016\/j.lfs.2023.121532_bb0410","article-title":"Benzodiazepine use and risk of Alzheimer's disease: case-control study","volume":"9","author":"De Gage","year":"2014","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.lfs.2023.121532_bb0415","doi-asserted-by":"crossref","first-page":"935","DOI":"10.3233\/JAD-180745","article-title":"Diazepam toxicity presenting as a dementia disorder","volume":"66","author":"Kurlawala","year":"2018","journal-title":"J. Alzheimers Dis."},{"issue":"2","key":"10.1016\/j.lfs.2023.121532_bb0420","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s12031-018-1246-4","article-title":"The \u03b15-containing GABAA receptors\u2014a brief summary","volume":"67","author":"Mohamad","year":"2019","journal-title":"J. Mol. Neurosci."},{"issue":"11","key":"10.1016\/j.lfs.2023.121532_bb0425","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3389\/fnagi.2019.00344","article-title":"Benzodiazepines and related drugs as a risk factor in Alzheimer's disease dementia","volume":"8","author":"Ettcheto","year":"2020","journal-title":"Front. Aging Neurosci."},{"issue":"8","key":"10.1016\/j.lfs.2023.121532_bb0430","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1111\/j.1460-9568.2004.03688.x","article-title":"Benzodiazepine impairment of perirhinal cortical plasticity and recognition memory","volume":"20","author":"Wan","year":"2004","journal-title":"Eur. J. Neurosci."},{"issue":"7S_Part_31","key":"10.1016\/j.lfs.2023.121532_bb0435","doi-asserted-by":"crossref","first-page":"P1622","DOI":"10.1016\/j.jalz.2018.07.211","article-title":"P4-387: unintended effects of Z-drugs (zolpidem, zopiclone and zaleplon) in people living with dementia","volume":"14","author":"Richardson","year":"2018","journal-title":"Alzheimers Dement."},{"issue":"9","key":"10.1016\/j.lfs.2023.121532_bb0440","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2021.e07895","article-title":"Prodromal dysfunction of \u03b15GABA-A receptor modulated hippocampal ripples occurs prior to neurodegeneration in the TgF344-AD rat model of Alzheimer's disease","volume":"7","author":"Ratner","year":"2021","journal-title":"Heliyon"},{"issue":"8","key":"10.1016\/j.lfs.2023.121532_bb0445","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.4103\/1673-5374.300987","article-title":"Therapeutic potential of alpha 5 subunit containing GABAA receptors in Alzheimer's disease","volume":"16","author":"Kwakowsky","year":"2021","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.lfs.2023.121532_bb0450","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1111\/cns.13914","article-title":"Effects of \u03b15 GABAA receptor modulation on social interaction, memory, and neuroinflammation in a mouse model of Alzheimer's disease","volume":"28","author":"Aran\u0111elovi\u0107","year":"2022","journal-title":"CNS Neurosci. Ther."},{"issue":"364","key":"10.1016\/j.lfs.2023.121532_bb0455","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.bbr.2019.02.016","article-title":"GABAA\/benzodiazepine receptors in the dorsal periaqueductal gray mediate the panicolytic but not the anxiolytic effect of alprazolam in rats","volume":"17","author":"Frias","year":"2019","journal-title":"Behav. Brain Res."},{"issue":"75","key":"10.1016\/j.lfs.2023.121532_bb0460","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neurobiolaging.2018.10.027","article-title":"Administration of the benzodiazepine midazolam increases tau phosphorylation in the mouse brain","volume":"1","author":"Whittington","year":"2019","journal-title":"Neurobiol. Aging"},{"issue":"183","key":"10.1016\/j.lfs.2023.121532_bb0465","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.trsl.2016.12.005","article-title":"Insulin resistance in Alzheimer's disease","volume":"1","author":"Diehl","year":"2017","journal-title":"Transl. Res."},{"issue":"4","key":"10.1016\/j.lfs.2023.121532_bb0470","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/JCP.0b013e318222810e","article-title":"Translocase of outer mitochondrial membrane 40 homolog (TOMM40) poly-T length modulates lorazepam-related cognitive toxicity in healthy APOE \u03b54-negative elderly","volume":"31","author":"Pomara","year":"2011","journal-title":"J. Clin. Psychopharmacol."},{"issue":"10","key":"10.1016\/j.lfs.2023.121532_bb0475","doi-asserted-by":"crossref","first-page":"4746","DOI":"10.4088\/JCP.08m04593","article-title":"Double-blind crossover study of the cognitive effects of lorazepam in healthy apolipoprotein E (APOE)-\u03b54 carriers","volume":"70","author":"Stonnington","year":"2009","journal-title":"J. Clin. Psychiatry"},{"issue":"4","key":"10.1016\/j.lfs.2023.121532_bb0480","doi-asserted-by":"crossref","first-page":"616","DOI":"10.4103\/1673-5374.230276","article-title":"Synaptic dysfunction in Alzheimer's disease: the effects of amyloid beta on synaptic vesicle dynamics as a novel target for therapeutic intervention","volume":"13","author":"Marsh","year":"2018","journal-title":"Neural Regen. Res."},{"issue":"2","key":"10.1016\/j.lfs.2023.121532_bb0485","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.bbr.2011.12.013","article-title":"Beneficial effects of benzodiazepine diazepam on chronic stress-induced impairment of hippocampal structural plasticity and depression-like behavior in mice","volume":"228","author":"Zhao","year":"2012","journal-title":"Behav. Brain Res."},{"issue":"128","key":"10.1016\/j.lfs.2023.121532_bb0490","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.neuropharm.2017.10.022","article-title":"Depolarizing, inhibitory GABA type A receptor activity regulates GABAergic synapse plasticity via ERK and BDNF signaling","volume":"1","author":"Brady","year":"2018","journal-title":"Neuropharmacology"},{"issue":"47","key":"10.1016\/j.lfs.2023.121532_bb0495","doi-asserted-by":"crossref","first-page":"41115","DOI":"10.1074\/jbc.M111.248534","article-title":"Dual functions of histone-lysine N-methyltransferase Setdb1 protein at promyelocytic leukemia-nuclear body (PML-NB): maintaining PML-NB structure and regulating the expression of its associated genes","volume":"286","author":"Cho","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.lfs.2023.121532_bb0500","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1159\/000491657","article-title":"The molecular mechanism of alpha-synuclein dependent regulation of protein phosphatase 2A activity","volume":"47","author":"Qu","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"issue":"7","key":"10.1016\/j.lfs.2023.121532_bb0505","first-page":"16","article-title":"Protein phosphatase 2A dysfunction in Alzheimer's disease","volume":"11","author":"Sontag","year":"2014","journal-title":"Front. Mol. Neurosci."},{"issue":"6","key":"10.1016\/j.lfs.2023.121532_bb0510","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/S0002-9440(10)62486-8","article-title":"Up-regulation of inhibitors of protein phosphatase-2A in Alzheimer's disease","volume":"166","author":"Tanimukai","year":"2005","journal-title":"Am. J. Pathol."},{"issue":"5","key":"10.1016\/j.lfs.2023.121532_bb0515","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/jnc.14325","article-title":"GABAA receptor subunit expression changes in the human Alzheimer's disease hippocampus, subiculum, entorhinal cortex and superior temporal gyrus","volume":"145","author":"Kwakowsky","year":"2018","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.lfs.2023.121532_bb0520","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/gps.4821","article-title":"Risk of death associated with new benzodiazepine use among persons with Alzheimer disease: a matched cohort study","volume":"33","author":"Saarelainen","year":"2018","journal-title":"Int. J. Geriatr. Psychiatry"},{"issue":"10","key":"10.1016\/j.lfs.2023.121532_bb0525","doi-asserted-by":"crossref","first-page":"695","DOI":"10.3389\/fphar.2019.00695","article-title":"Sleep and \u03b2-amyloid deposition in Alzheimer disease: insights on mechanisms and possible innovative treatments","volume":"20","author":"Cordone","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"8","key":"10.1016\/j.lfs.2023.121532_bb0530","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1016\/j.neurobiolaging.2014.02.011","article-title":"Sleep deprivation impairs memory, tau metabolism, and synaptic integrity of a mouse model of Alzheimer's disease with plaques and tangles","volume":"35","author":"Di Meco","year":"2014","journal-title":"Neurobiol. Aging"},{"issue":"64","key":"10.1016\/j.lfs.2023.121532_bb0535","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.bbi.2017.04.007","article-title":"Chronic sleep restriction promotes brain inflammation and synapse loss, and potentiates memory impairment induced by amyloid-\u03b2 oligomers in mice","volume":"1","author":"Kincheski","year":"2017","journal-title":"Brain Behav. Immun."},{"issue":"10","key":"10.1016\/j.lfs.2023.121532_bb0540","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.5665\/sleep.3052","article-title":"Midlife sleep characteristics associated with late life cognitive function","volume":"36","author":"Virta","year":"2013","journal-title":"Sleep"},{"issue":"4","key":"10.1016\/j.lfs.2023.121532_bb0545","doi-asserted-by":"crossref","first-page":"99","DOI":"10.12779\/dnd.2021.20.4.99","article-title":"Amyloid burden in Alzheimer's disease patients is associated with alterations in circadian rhythm","volume":"20","author":"Kang","year":"2021","journal-title":"Dement. Neurocogn. Disord."},{"issue":"1","key":"10.1016\/j.lfs.2023.121532_bb0550","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41386-019-0478-5","article-title":"Bidirectional relationship between sleep and Alzheimer's disease: role of amyloid, tau, and other factors","volume":"45","author":"Wang","year":"2020","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.lfs.2023.121532_bb0555","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0170275","article-title":"Optogenetic restoration of disrupted slow oscillations halts amyloid deposition and restores calcium homeostasis in an animal model of Alzheimer's disease","volume":"12","author":"Kastanenka","year":"2017","journal-title":"PloS one"},{"issue":"1","key":"10.1016\/j.lfs.2023.121532_bb0560","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-44964-z","article-title":"Frequency-dependent exacerbation of Alzheimer's disease neuropathophysiology","volume":"9","author":"Kastanenka","year":"2019","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.lfs.2023.121532_bb0565","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1471-4159.2010.06961.x","article-title":"Increased caspase activation and decreased TDP-43 solubility in progranulin knockout cortical cultures","volume":"115","author":"Kleinberger","year":"2010","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.lfs.2023.121532_bb0570","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2174\/156720511795256053","article-title":"EHT0202 in Alzheimer's disease: a 3-month, randomized, placebo-controlled, double-blind study","volume":"8","author":"Vellas","year":"2011","journal-title":"Curr. Alzheimer Res."},{"issue":"4","key":"10.1016\/j.lfs.2023.121532_bb0575","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.neures.2005.04.008","article-title":"Chronic stimulation of GABAA receptor with muscimol reduces amyloid \u03b2 protein (25\u201335)-induced neurotoxicity in cultured rat cortical cells","volume":"52","author":"Lee","year":"2005","journal-title":"Neurosci. Res."},{"issue":"1","key":"10.1016\/j.lfs.2023.121532_bb0580","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2047-9158-3-8","article-title":"Chronic treatment with anesthetic propofol attenuates \u03b2-amyloid protein levels in brain tissues of aged mice","volume":"3","author":"Zhang","year":"2014","journal-title":"Transl. Neurodegener."},{"issue":"1","key":"10.1016\/j.lfs.2023.121532_bb0585","doi-asserted-by":"crossref","first-page":"102","DOI":"10.5114\/aoms.2011.20612","article-title":"Tramiprosate in mild-to-moderate Alzheimer's disease\u2013a randomized, double-blind, placebo-controlled, multi-centre study (the Alphase Study)","volume":"7","author":"Aisen","year":"2011","journal-title":"Arch. Med. Sci."},{"issue":"15","key":"10.1016\/j.lfs.2023.121532_bb0590","doi-asserted-by":"crossref","first-page":"4668","DOI":"10.1021\/jm801599a","article-title":"Synthesis, in vivo evaluation, and molecular modeling studies of new pyrazolo [5, 1-c][1, 2, 4] benzotriazine 5-oxide derivatives. Identification of a bifunctional hydrogen bond area related to the inverse agonism","volume":"52","author":"Guerrini","year":"2009","journal-title":"J. Med. Chem."},{"issue":"13","key":"10.1016\/j.lfs.2023.121532_bb0595","doi-asserted-by":"crossref","first-page":"3788","DOI":"10.1021\/jm701433b","article-title":"Selective influence on contextual memory: physiochemical properties associated with selectivity of benzodiazepine ligands at GABAA receptors containing the \u03b15 subunit","volume":"51","author":"Harris","year":"2008","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.lfs.2023.121532_bb0600","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/BF02246647","article-title":"The effects of a benzodiazepine receptor antagonist \u03b2-carboline ZK-93426 on scopolamine-induced impairment on attention, memory and psychomotor skills","volume":"123","author":"Duka","year":"1996","journal-title":"Psychopharmacology"},{"issue":"5","key":"10.1016\/j.lfs.2023.121532_bb0605","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019264","article-title":"\u03b2-Carboline compounds, including harmine, inhibit DYRK1A and tau phosphorylation at multiple Alzheimer's disease-related sites","volume":"6","author":"Frost","year":"2011","journal-title":"Plos one"},{"issue":"125","key":"10.1016\/j.lfs.2023.121532_bb0610","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.neuropharm.2017.08.012","article-title":"Selective inhibition of extra-synaptic \u03b15-GABAA receptors by S44819, a new therapeutic agent","volume":"1","author":"Etherington","year":"2017","journal-title":"Neuropharmacology"},{"issue":"10","key":"10.1016\/j.lfs.2023.121532_bb0615","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1007\/s00415-020-09937-7","article-title":"Seizures in Alzheimer's disease are highly recurrent and associated with a poor disease course","volume":"267","author":"V\u00f6glein","year":"2020","journal-title":"J. Neurol."},{"issue":"7","key":"10.1016\/j.lfs.2023.121532_bb0620","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1111\/jgs.17101","article-title":"Systematic review of coexistent epileptic seizures and Alzheimer's disease: incidence and prevalence","volume":"69","author":"Xu","year":"2021","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.lfs.2023.121532_bb0625","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1007\/s12035-018-1237-z","article-title":"APOE and Alzheimer's disease: evidence mounts that targeting APOE4 may combat Alzheimer's pathogenesis","volume":"56","author":"Uddin","year":"2019","journal-title":"Mol. Neurobiol."},{"issue":"9","key":"10.1016\/j.lfs.2023.121532_bb0630","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41582-019-0228-7","article-title":"Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies","volume":"15","author":"Yamazaki","year":"2019","journal-title":"Nat. Rev. Neurol."},{"issue":"2","key":"10.1016\/j.lfs.2023.121532_bb0635","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.neuron.2020.10.008","article-title":"Apolipoprotein E: structural insights and links to Alzheimer disease pathogenesis","volume":"109","author":"Chen","year":"2021","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.lfs.2023.121532_bb0640","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-020-0358-9","article-title":"Therapeutic approaches targeting Apolipoprotein E function in Alzheimer's disease","volume":"15","author":"Williams","year":"2020","journal-title":"Mol. Neurodegener."},{"issue":"6","key":"10.1016\/j.lfs.2023.121532_bb0645","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.stem.2009.10.015","article-title":"GABAergic interneuron dysfunction impairs hippocampal neurogenesis in adult apolipoprotein E4 knockin mice","volume":"5","author":"Li","year":"2009","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10.1016\/j.lfs.2023.121532_bb0650","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/00002093-199803000-00002","article-title":"Benzodiazepines may have protective effects against Alzheimer disease","volume":"12","author":"Fastbom","year":"1998","journal-title":"Alzheimer Dis. Assoc. Disord."},{"issue":"5","key":"10.1016\/j.lfs.2023.121532_bb0655","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/s41386-021-01246-5","article-title":"Benzodiazepine use and neuroimaging markers of Alzheimer's disease in nondemented older individuals: an MRI and 18F Florbetapir PET study in the MEMENTO cohort","volume":"47","author":"Gallet","year":"2022","journal-title":"Neuropsychopharmacology"},{"issue":"84","key":"10.1016\/j.lfs.2023.121532_bb0660","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.neurobiolaging.2019.08.008","article-title":"Benzodiazepine use and brain amyloid load in nondemented older individuals: a florbetapir PET study in the multidomain Alzheimer preventive trial cohort","volume":"1","author":"Desmidt","year":"2019","journal-title":"Neurobiol. Aging"},{"issue":"2","key":"10.1016\/j.lfs.2023.121532_bb0665","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jamda.2019.08.006","article-title":"Cognitive outcomes of long-term benzodiazepine and related drug (BDZR) use in people living with mild to moderate Alzheimer's disease: results from NILVAD","volume":"21","author":"Dyer","year":"2020","journal-title":"J. Am. Med. Dir. Assoc."},{"issue":"3","key":"10.1016\/j.lfs.2023.121532_bb0670","first-page":"107","article-title":"Association between benzodiazepine use and development of dementia","volume":"156","author":"Aldaz","year":"2021","journal-title":"Med. Cl\u00edn. (Engl. Ed.)"},{"issue":"1","key":"10.1016\/j.lfs.2023.121532_bb0675","article-title":"Benzodiazepine use and the risk of dementia","volume":"8","author":"Joyce","year":"2022","journal-title":"Alzheimers Dement."},{"issue":"3","key":"10.1016\/j.lfs.2023.121532_bb0680","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/1060028019882037","article-title":"Is benzodiazepine use associated with the risk of dementia and cognitive impairment\u2013not dementia in older persons? The Canadian study of health and aging","volume":"54","author":"Nafti","year":"2020","journal-title":"Ann. Pharmacother."},{"issue":"2","key":"10.1016\/j.lfs.2023.121532_bb0685","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jamda.2019.08.017","article-title":"Uncertain association between benzodiazepine use and the risk of dementia: a cohort study","volume":"21","author":"Baek","year":"2020","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"10.1016\/j.lfs.2023.121532_bb0690","series-title":"Essential Reviews in Geriatric Psychiatry","first-page":"35","article-title":"A systematic review and meta-analysis of the risk of dementia associated with benzodiazepine use, after controlling for protopathic bias","author":"Mitra","year":"2022"},{"issue":"1","key":"10.1016\/j.lfs.2023.121532_bb0695","doi-asserted-by":"crossref","first-page":"4634","DOI":"10.1038\/s41598-018-22979-2","article-title":"An acute functional screen identifies an effective antibody targeting amyloid-\u03b2 oligomers based on calcium imaging","volume":"8","author":"Wang","year":"2018","journal-title":"Sci. Rep."},{"issue":"14","key":"10.1016\/j.lfs.2023.121532_bb0700","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3389\/fnins.2020.00705","article-title":"Slow wave sleep is a promising intervention target for Alzheimer's disease","volume":"30","author":"Lee","year":"2020","journal-title":"Front. Neurosci."},{"issue":"1","key":"10.1016\/j.lfs.2023.121532_bb0705","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4103\/japtr.JAPTR_330_18","article-title":"Effects of rosuvastatin on metabolic profile: versatility of dose-dependent effect","volume":"10","author":"Al-Kuraishy","year":"2019","journal-title":"J. Adv. Pharm. Technol. Res."},{"issue":"5","key":"10.1016\/j.lfs.2023.121532_bb0710","doi-asserted-by":"crossref","first-page":"101","DOI":"10.4103\/bbrj.bbrj_109_20","article-title":"Is ivermectin\u2013azithromycin combination the next step for COVID-19?","volume":"4","author":"Al-Kuraishy","year":"2020","journal-title":"Biomed. Biotechnol. Res. J."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320523001662?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320523001662?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T21:09:59Z","timestamp":1758402599000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320523001662"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":142,"alternative-id":["S0024320523001662"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2023.121532","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insights on benzodiazepines' potential in Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2023.121532","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"121532"}}